Retirement Group’s AbbVie ABBV Stock Holding History

Retirement Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$308K	Buy	1,691 +128	+8%	+$22.1K	0.11%	89
2023 Q4	$242K	Hold	1,563	–	–	0.1%	91
2023 Q3	$233K	Sell	1,563 -25	-2%	-$3.67K	0.1%	89
2023 Q2	$214K	Hold	1,588	–	–	0.09%	93
2023 Q1	$253K	Hold	1,588	–	–	0.12%	78
2022 Q4	$257K	Buy	1,588 +1,221	+333%	+$187K	0.12%	68
2022 Q3	$49K	Sell	367 -2,427	-87%	-$348K	0.04%	124
2022 Q2	$428K	Buy	2,794 +1,208	+76%	+$185K	0.18%	69
2022 Q1	$257K	Buy	1,586 +17	+1%	+$2.47K	0.1%	101
2021 Q4	$212K	Hold	1,569	–	–	0.09%	113
2021 Q3	$169K	Hold	1,569	–	–	0.08%	129
2021 Q2	$177K	Sell	1,569 -152	-9%	-$17.1K	0.09%	125
2021 Q1	$186K	Buy	1,721 +106	+7%	+$11.3K	0.08%	138
2020 Q4	$173K	Buy	1,615 +1,288	+394%	+$124K	0.08%	135
2020 Q3	$29K	Buy	327 +81	+33%	+$7.63K	0.02%	291
2020 Q2	$24K	Buy	+246	New	+$21.7K	0.01%	300
2019 Q4	$1K	Buy	+10	New	+$830	﹤0.01%	564

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Retirement Group's ABBV Position: Q1 2024 in Review

Retirement Group increased its AbbVie (ABBV) stake by 8.2% in Q1 2024, buying an estimated $22.1K and bringing the position to 1,691 shares worth $308K. The position accounts for 0.11% of the portfolio, ranked #89.

Retirement Group first reported a position in ABBV in Q4 2019 and has held it in 17 quarters since. The position peaked at $428K in Q2 2022. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

Retirement Group held 1,691 shares of AbbVie worth $308K as of Q1 2024.
Retirement Group bought 128 AbbVie shares in Q1 2024, an estimated $22.1K.
AbbVie made up 0.11% of Retirement Group's portfolio in Q1 2024, its #89 holding.
Retirement Group first reported a position in AbbVie in Q4 2019 and has held it in 17 quarters since.
Retirement Group's AbbVie position peaked at $428K in Q2 2022.
3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Retirement Group's 13F filing for Q1 2024, filed 30 Apr 2024.